ABEVMY
ABEVMY
Approved
DIN Number
02522160
Drug Class
Human
Market Date
Apr 13, 2022
Company
HC
Biosimilar Collaborations Ireland Ltd.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02522160
AIG Number0151381001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L01FG01 BEVACIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
BEVACIZUMABActive
Strength: 400 MG / 16 ML
Monograph: BEVACIZUMAB